Back to Top

"One of today's leaders in investor relations and shareholder services"

Author Archives: Tom

Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com

AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. and ChineseInvestors.com (OTCQB:CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, and a well-known cannabidiol (CBD) health brand engaged in the development, manufacturing, marketing and distribution of consumer products containing CBD, today announce that the Company’s director of investor relations, Alan Klitenic, is featured in an audio interview at SmallCapVoice.com.

The interview outlining CIIX’s current news and efforts can be heard at http://smallcapvoice.com/blog/9-18-17-smallcapvoice-interview-with-chineseinvestors-com-inc-ciix.

Alan Klitenic, director of investor relations for ChineseInvestors.com called in to SmallCapVoice.com, Inc. to discuss the recent news for the company. Topics covered in the interview include the recent news in the Digital Currency Industry, the plans that the Company has regarding launching a Chinese Daily Video News Broadcast from the NYSE floor covering the Digital Currency Market, exciting news about its recent financial performance, and insights …

Continue Reading

Posted in Client News| Tagged , , |
Chineseinvestors.com, Inc. (CIIX)

9-18-17 SmallCapVoice Interview with Chineseinvestors.com, Inc. (CIIX)

Chineseinvestors.com, Inc. (CIIX)

Alan Klitenic, director of investor relations for ChineseInvestors.com (OTCQB: CIIX) the premier financial information website for Chinese-speaking investors in both the U.S. and China, and a well-known cannabidiol (CBD) health brand engaged in the development, manufacturing, marketing and distribution of consumer products containing CBD called in to SmallCapVoice.com, Inc. to discuss the recent news for the company. Topics covered in the interview include the recent news in the Digital Currency Industry, the plans Company has regarding launching a Chinese Daily Video News Broadcast from the NYSE floor covering the Digital Currency Market, exciting news about its recent financial performance, and insights on all recent news.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary …

Continue Reading

Posted in Interviews| Tagged |

Michael T. Redman, Chairman of the Board and CEO of Oncolix, Inc., is Featured in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Sept. 19, 2017 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and Oncolix, Inc. (Pink Sheets: AEPP), a clinical-stage biotechnology company developing Prolanta™ for the treatment of ovarian cancer, today announced that a new audio interview with the Company is now available. The interview can be heard at http://smallcapvoice.com/blog/9-12-17-smallcapvoice-interview-with-oncolix-inc-aepp.

Michael T. Redman called in to SmallCapVoice.com to go over the business model, management, the ongoing Phase I human clinical trial in ovarian cancer patients and the FDA granting Prolanta Orphan Drug status for the treatment of ovarian cancer in this new interview. Recently the Company consummated a private placement of debt securities, resulting in gross proceeds of $2.0 million. Newbridge Securities Corporation, through LifeTech Capital, acted as lead placement agent for the offering and as financial advisor for the merger.

In the interview Mr. Redman stated, “Our management team is quite diverse because we have experience running companies both big …

Continue Reading

Posted in Client News| Tagged |
Oncolix, Inc. (AEPP)

9-12-17 SmallCapVoice Interview with Oncolix, Inc. (AEPP)

Oncolix, Inc. (AEPP)

Michael T. Redman, Chairman of the Board of AEPP, called in to SmallCapVoice.com to go over their cancer drug Prolanta™,a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer. This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for …

Continue Reading

Posted in Interviews| Tagged |

ChineseInvestors.com, Inc.’s Wholly Owned Foreign Enterprise, CBD Biotechnology Co. Ltd., Completes the Record Filing Process with the China FDA, Expects to Launch its Hemp Infused Skin Care Line in October

SAN GABRIEL, California, September 18, 2017 /PRNewswire/ — ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., has completed the filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. The Company expects to launch the CBD Magic Hemp Series skin care line in October positioning CBD Biotechnology as a leader in what it believes to be an untapped segment of China’s skin care industry. 

The CBD Magic Hemp Series launch will include three (3) products:  

  • The CBDBIO TECH Brightening and Refreshing Moisturizer – intended to balance the skin’s moisture, while forming a protective, moisturizing layer;
  • The CBDBIO TECH Perfecting Shield Primer – intended to even skin tone, while covering fine lines and minimizing the look of pores; and
  • The CBDBIO TECH Peptide Collagen Solution – intended to moisturize and firm the skin, while smoothing fine lines, and reducing signs of aging.

The CBD Magic Hemp Series line is different from other …

Continue Reading

Posted in Client News| Tagged |

Rocky Mountain High Brands Announces Interview with Michael Welch Concerning Recent Board Changes

DALLAS, Sept. 15, 2017 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline spring water, today announced that a new audio interview between Stuart Smith of SmallCapVoice.com and Michael Welch, the Company’s President, CEO and recently named Chairman of the Board is now available for listening. Mr. Welch discussed the continued commitment of both Gerry David and Kevin Harrington to Rocky Mountain High Brands and the reasons behind their recent resignations from the Board of Directors.

The interview can be heard at:

http://smallcapvoice.com/blog/9-14-17-smallcapvoice-interview-with-rocky-mountain-high-brands-inc-rmhb

The Company filed a Form 8-K with the Securities and Exchange Commission on September 14, 2017. The filing can be reviewed at:

https://www.sec.gov/Archives/edgar/data/1670869/000166357717000292/mainbody.htm

About SmallCapVoice.com:

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among …

Continue Reading

Posted in Client News| Tagged , , |